Biogen eyes Regenxbio delivery tech for candidate occular gene therapies
Biogen has licensed rights use a gene therapy delivery technology from developer Regenxbio.
Archives for May 16, 2016
Fosun Pharmaceutical confirms bid for India’s Gland Pharma
Shanghai Fosun Pharmaceutical has confirmed it made a takeover bid for Indian sterile injectable drug firm Gland Pharma.
Will Pfizer renew with Icon, Parexel? Analyst says yes
This month marks the renewal period for Pfizer’s contract research organizations’ Icon and Parexel, and while revenues have been declining, analysts believe the pharma giant will renew with both companies.
Fermion invests $33m to add HPAPI capacity at Hanko plant
Fermion will invest €30m ($33m) to expand its API facility in Hanko, Finland to build its high potency drug ingredient manufacturing business.
Juniper invests in mixer tech for UK plant
Juniper Pharma Services has upped mixing capacity at its facility in Nottingham, UK to give it the ability to support Phase III studies of topical and semi-solid products.
MPA withdraws Bend's Oregon plant GMP certificate citing deficiencies
Swedish regulators have withdrawn a GMP certificate issued to Bend Research after deeming the firm’s plan to address deviations at its Oregon plant “partly unacceptable.”
Preclinical outsourcing to grow 20% in 2016 says new report
More drug discovery work will be outsourced this year according to a report which suggests pharmaceutical industry desire to reduce the risk of failure and cut costs persists.